$13.79
▲ +$0.09
(+0.66%)
Vol 662K
11
Quality Score
ok
Deep Check
2/5
ok
Rev ✓
NI ✓
>IPO ✗
Mkt Cap
$928.5M
P/E
6.2
ROE
23.0%
Margin
41.1%
D/E
0.00
Beta
2.22
52W
$13–$20
Wall Street Consensus
13 analysts · Apr 20263
Strong Buy
4
Buy
6
Hold
0
Sell
0
Strong Sell
53.8%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 75.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $0.43 | $0.46 | +$0.03 |
| Sep 2025 | $0.36 | $0.38 | +$0.02 |
| Jun 2025 | $0.42 | $0.47 | +$0.05 |
| Mar 2025 | $0.36 | $0.31 | $-0.05 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $97.9M | $77.9M | $95.6M | $93.2M | $103.9M |
| Net Income | — | $82.8M | $18.2M | $26.7M | $21.9M | $27.0M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 26.6% | 26.6% | 26.6% | 26.6% | 23.0% | 23.0% |
| P/E (TTM) | 5.10 | 5.52 | 5.96 | 5.75 | 6.63 | 6.20 |
| Net Margin | 28.0% | 44.5% | 44.5% | 44.5% | 41.1% | 41.1% |
| Gross Margin | 80.0% | 80.0% | 80.0% | 80.0% | 78.8% | 78.8% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 9.60 | 9.60 | 9.60 | 9.60 | 9.75 | 9.75 |
Key Ratios
ROA (TTM)
20.4%
P/S (TTM)
2.55
P/B
1.8
EPS (TTM)
$2.16
CF/Share
$2.11
Rev Growth 3Y
+3.4%
52W High
$19.78
52W Low
$13.14
$13.14
52-Week Range
$19.78
Financial Health
Free Cash Flow
$22.1M
Net Debt
-$294.3M
Cash
$302.5M
Total Debt
$8.2M
As of Dec 31, 2025
How does INMD compare to Health Care peers?
Peer group: Micro-cap Health Care (All) · 241 companies
INMD valuation vs Health Care peers
P/E ratio
6.2
▼
80%
below
peers
(30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
2.6
▼
1%
below
peers
(2.6)
vs Peers
vs Industry
Fair value
P/B ratio
1.8
▼
35%
below
peers
(2.8)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.7%)
vs Peers
vs Industry
Low yield
INMD profitability vs Health Care peers
ROE
23.0%
▲
160%
above
peers
(-38.5%)
vs Peers
vs Industry
Top tier
Net margin
41.1%
▲
266%
above
peers
(-24.7%)
vs Peers
vs Industry
Top tier
Gross margin
78.8%
▲
49%
above
peers
(52.9%)
vs Peers
vs Industry
Top tier
ROA
20.4%
▲
196%
above
peers
(-21.2%)
vs Peers
vs Industry
Top tier
INMD financial health vs Health Care peers
D/E ratio
0.0
▼
100%
below
peers
(19.3)
vs Peers
vs Industry
Low debt
Current ratio
9.8
▲
351%
above
peers
(2.2)
vs Peers
vs Industry
Strong liquidity
Beta
2.2
▲
112%
above
peers
(1.1)
vs Peers
vs Industry
More volatile
INMD fundamentals radar
INMD
Peer median
Industry
INMD profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
INMD vs peers: key metrics
Related Signals
Latest AI Opinion
Grok
BUY
Price action shows the stock has dipped to recent lows around $13.29-$13.73 over the past few weeks after peaking near $16.65 in early February 2026, positioning $13.79 as a potential good entry point on this support level with signs of …
Mar 24, 2026Top Holders
Top 5: 18.55%Doma Perpetual Capital Mana…
4.48%
$38.6M
Acadian Asset Management. L…
4.10%
$35.3M
Renaissance Technologies, L…
3.85%
$33.1M
Blackrock Inc.
3.31%
$28.5M
Millennium Management Llc
2.81%
$24.2M
As of Dec 31, 2025
Latest News
No related news yet